Recurrent Non-small Cell Lung Cancer Completed Phase Trials for Erlotinib (DB00530)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00085280Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTreatment